Look whoβs a new MD! Congrats @mallwood, who is ready to take in residency in anesthesiology by storm at McMaster next... #proudPI way to go Mo!! lab phd alumni.... π @prof_brunt@UofG_HHNS
@glenpyle Now....Is this really imposter syndrome??!? By the way, your wife makes an amazing looking pie, Iβll await my slice in the mail #SocialDistancing
@glenpyle@MutsaersLab@uofg Me too! ... always an amazing concert with those guys. So sad to hear he has passed, a Canadian music legend! I was fortunate enough to catch one of their last concert in Toronto... from #SOTW in PCH to Massey hall and all the years in between, thank you John
The fatty acid derivative palmitoylcarnitine abrogates colorectal cancer cell survival by depleting glutathione | American Journal of Physiology-Cell Physiology https://t.co/KxbzqU8nGe
Why does 'activating' mitochondria kill some cancers but not others? We provide evidence (colon vs breast) that this may be related to the ability of a cancer to maintain glutathione in response to mitochondrial ROS. Work by Patrick Turnbull in our lab.
https://t.co/edY9z0JWv7
Online today in JCSM. Meghan Hughes, Sofhia Ramos et al identified more precise mitochondrial deficits in a mouse model of Duchenne muscular dystrophy. Ongoing studies are testing mitochondrial-targeted compounds to slow muscle weakness in this disease. https://t.co/e7Ma8uKRwE
Therapeutic Potential of Targeting Γ-Arrestin https://t.co/B8tNajKQSr
Nicely done, beautifully written and thorough review...Such huge potential for new therapeutics! #lung#drugdiscovery#pharmacology@AirwyResistance @DukeU_NrsngSchl @andrewfosster
Important findings and great work by @HughesMeghan, Sofhia Ramos, and all involved - absolutely grateful for support and expertise in cardiac physiology from @Jerm73@BrittanyEdgett @huber_s_jay and Peter Backx group! Should heart mitochondria be targeted early in Duchenne?